论文信息 - Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer - 字舞流文

Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer

H. Ueno | T. Kohno | T. Shibata | N. Hiraoka | N. Sakamoto | H. Ichikawa | Mamoru Kato | T. Okusaka | K. Shimada | S. Kondo | M. Saito | Y. Komatsu | C. Morizane | Yoko Shimada | H. Hayashi | Y. Sakamoto